Our
Clients
: Aug, 2020
: 100
:
Prostate Specific Antigen (PSA) Testing Market: Description
A prostate-specific antigen (PSA) test estimates the degree of PSA in your blood. The prostate is considered as an internal organ present in a male reproductive system. It is located underneath the bladder and makes a liquid that is essential for production. PSA is a substance that is made by the prostate. Men generally have low PSA levels in their blood. A high PSA level might be an indication of prostate cancer growth, the most common non-skin disease effecting American men. Although high PSA levels can also mean noncancerous prostate circumstances, like disease or harmless prostatic hyperplasia, a noncancerous expansion of the prostate.
A PSA test is utilized to diagnose for prostate cancer. Screening is a test that searches for an infection, like disease, in its initial phases, when it's treatable. Driving health associations, like the American Cancer Society and the Centres for Disease Control and Prevention (CDC), differ on suggestions for utilizing the PSA test for cancer screening.
Source: WMR
Prostate Specific Antigen (PSA) Testing Market: Overview
The global Prostate Specific Antigen (PSA) Testing Market size was USD 3,120 million in 2022, and is expected to grow at a value of more than USD 5,880 million by 2033, with a growing CAGR (Compound annual growth rate) of over 11% from 2023 to 2033.
Throughout the esteem time period, technological advancements in diagnostic tests are relied upon to help boost market extension. Specialists are at present concentrating on the utilization of Artificial Intelligence (AI) to distinguish prostate cancer growth, as indicated by the National Cancer Institute. Artificial intelligence (AI) calculations are used to identify troubling spots seen during an MRI filter that expect biopsies to affirm the presence of cancer cells. Artificial intelligence techniques are additionally being tried to further develop biopsy test examination with the goal to come up with productive and exact outcomes.
One more variable that is relied upon to fuel the extension of the prostate cancer diagnostics market is the expanding number of new market contenders. In contrast with standard PSA testing, this gadget is anticipated to provide extremely sensitive test discoveries. Therefore, expanded speculation by new participants is probably going to fuel significant market development. The excessive cost of the tests, then again, is likely to impede industry growth. Significant supporters of the development of the worldwide prostate specific antigen (PSA) testing market are amplifying in reception of serum-based marker testing for the diagnosis of prostate cancer alongside its assessment with other creating cancer-specific markers, which upgrades the overall sensitivity of the test. In any case, risk of overtreatment and wrong diagnosis as a resultant of PSA screening can hinder the progression of this market.
Source: WMR
Prostate Specific Antigen (PSA) Testing Market: Key Trends
Expanded Level of Awareness
Attributable to the developing aged populace, the market for prostate specific antigen testing is boosting. Rising public awareness about the advantages of prostate cancer screening, technological advancement in testing and treating prostate cancer, and an assortment of repayment approaches for prostate cancer growth, availability of medicines in different developed and developing countries are all impacting the development of the prostate specific antigen market. As indicated by the 2017 National Population Projections from the United States Census Bureau. By 2030, all baby boomers will age 60 or above. This reflects the expanding number of the geriatric populace.
False-positive or false-negative result of PSA
Ascribed to false positive or false negative PSA test discoveries, the prostate specific antigen testing market is subjected to severe challenges. Furthermore, the majority of these tests, like PSA Screening, have a few antagonistic impacts, for example, trouble passing urine, consequences on bowel function, erectile brokenness, and regular hurts, are hampering the development of the Prostate Specific Antigen Testing market. Higher innovative progressions leading to a smoothed out and precise outcome in tests like the Prostate Health Index (phi) may slow the development of the PSA testing industry except if the manner in which the tests are handled is changed.
Prostate Specific Antigen (PSA) Testing Market: Segmentation Analysis
Key players:
bbott Laboratories Inc.
Bayer AG
Beckman Coulter Inc.
GE Healthcare
GlaxoSmithKline plc
Novartis Pharma AG
UroLogix Inc.
Bristol - Myers Squibb Company
AstraZeneca plc
MDx Health
Myriad Genetics Inc.
F. Hoffman-La Roche AG
OPKO Health Inc.
Genomic Health
DiaSorin
Roche
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch (LABORIE)
BodiTech
Others
Prostate Specific Antigen (PSA) Testing Market: By Test Procedure
Preliminary Tests
Confirmatory Tests
Due to an increment in the recurrence of prostate cancer, the Preliminary Tests segment is probably going to hold the largest market share. The American Institute for Cancer Research asserts that the far and wide accessibility of PSA screening has helped early recognition and therapy, bringing about higher endurance rates. PSA testing are reliable to identify the undetected and small lesions that could possibly advance to a further developed phase of disease. Most men beyond 50 years old, as well as those belonging to the risk group should go for these tests since it can help diagnosing the illness before genuine side effects emerge.
Source: WMR
Prostate Specific Antigen (PSA) Testing Market: By Test Type
Total Prostate Specific Angiten Test (tPSA)
Complex Prostate Specific Antigen Test (cPSA)
Free Prostate Specific Antigen Test (fPSA)
Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR)
PCA3Test
Trans-rectal Ultrasound
Biopsy
Among these, the biopsy segment is anticipated to grow significantly over the forecast period owing to rising prevalence of cancer across the globe.
Prostate Specific Antigen (PSA) Testing Market: By Assays Type
Radioimmunoassay (RIA)
Enzyme immunoassay (EIA)
Prostate Specific Antigen (PSA) Testing Market: By Application
Screening
Post-treatment monitoring
Others
Among these, post treatment monitoring segment is anticipated to gain traction over the forecast duration due to rising concerns about the after effect of medical treatment procedures like surgeries.
Prostate Specific Antigen (PSA) Testing Market: Geographical ambit
In term of geography, the worldwide market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Among the areas, North America is anticipated to dominate the market and is probably going to be firmly trailed by Europe as prostate cancer is the most common type of cancer found in men in these regions.
The ensuing high death rate in various developed countries and rising frequency of prostate cancer in this area are the elements are positively swaying the dynamics of Prostate Specific Antigen (PSA) Testing Market during the forecast duration. Likewise, rising government initiatives aiming at the quick diagnosis of prostate cancer among the masses and advancement in medical services are accounted to support the progression of Prostate Specific Antigen (PSA) Testing Market in the region.
Prostate Specific Antigen (PSA) Testing Market: Competitive Landscape
The major players operating in this market are Abbott Laboratories Inc., Bayer AG, Beckman Coulter Inc., GE Healthcare, GlaxoSmithKline plc, Novartis Pharma AG, UroLogix Inc., Bristol - Myers Squibb Company, AstraZeneca plc, MDx Health, Myriad Genetics Inc., F. Hoffman-La Roche AG, OPKO Health Inc., Genomic Health, DiaSorin, Roche, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech, and Others.
Notably, GE Healthcare in October 2019 joined hands with Theragnostics to collaboratively develop a new Prostate-Specific Membrane Antigen PET/CT imaging agent.
Report Scope:
Prostate Specific Antigen (PSA) Testing Market Forecast Years: 2023-2033
Prostate Specific Antigen (PSA) Testing Market Historical Years: 2020-2021
Prostate Specific Antigen (PSA) Testing Market 2022: USD 3,120 million
Prostate Specific Antigen (PSA) Testing Market 2033: USD 5,880 million
Prostate Specific Antigen (PSA) Testing Market CAGR: 11.2%
Key Segments Reported:
By test procedure (preliminary tests and confirmatory tests)
By test type (total prostate specific antigen test (tPSA), complex prostate specific antigen test (cPSA), free prostate specific antigen test (fPSA), prostate specific antigen reverse transcription polymerase chain reaction test (PSA RT-PCR), PCA3Test, Trans-rectal ultrasound, and biopsy)
By assays type (radioimmunoassay (RIA) and enzyme immunoassay (EIA)
By application (screening, post-treatment monitoring, and others.)
Key Regions & Countries: North America (the United States, Canada, and Mexico), Europe (Germany, France, UK, Russia, and Italy), Asia-Pacific (China, Japan, Korea, India, and Southeast Asia), South America (Brazil, Argentina, Colombia, etc.), and The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa).
1. Global Prostate Specific Antigen (PSA) Testing Market Introduction and Market Overview
1.1. Objective of the Market Research Study
1.2. Prostate Specific Antigen (PSA) Testing Market Definition & Description
1.3. Research Data Parameters & Reporting Timelines
1.3.1. Historical Data Reporting Years 2020 to 2021
1.3.2. Projected Data Reporting Years 2023 to 2033
1.3.3. Reporting Data Parameters Value (US$ Million)
1.4. Global Prostate Specific Antigen (PSA) Testing Market Scope and Market Estimation
1.4.1. Global Prostate Specific Antigen (PSA) Testing Overall Market Size (US$ Million), Market CAGR (%), Market Estimates & Forecast (2020 to 2033)
1.4.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2020 to 2033
1.5. Prostate Specific Antigen (PSA) Testing Market Segmentation
1.5.1. Test Procedure of Global Prostate Specific Antigen (PSA) Testing Market
1.5.2. Test Type of Global Prostate Specific Antigen (PSA) Testing Market
1.5.3. Assays type of Global Prostate Specific Antigen (PSA) Testing Market
1.5.4. Application of Global Prostate Specific Antigen (PSA) Testing Market
1.5.5. Key Regions of Global Prostate Specific Antigen (PSA) Testing Market
2. Global Prostate Specific Antigen (PSA) Testing Market - Executive Summary
2.1. Global Prostate Specific Antigen (PSA) Testing Market Summary & Snapshot
2.2. Global Prostate Specific Antigen (PSA) Testing Market, By Test Procedure (US$ Million)
2.3. Global Prostate Specific Antigen (PSA) Testing Market, By Test Type (US$ Million)
2.4. Global Prostate Specific Antigen (PSA) Testing Market, By Assays type (US$ Million)
2.5. Global Prostate Specific Antigen (PSA) Testing Market, By Application (US$ Million)
2.6. Global Prostate Specific Antigen (PSA) Testing Market, By Geography (US$ Million)
2.7. Global Prostate Specific Antigen (PSA) Testing Market Outlook & Future Opportunities
3. Prostate Specific Antigen (PSA) Testing Market Trends, Outlook, and Factors Analysis
3.1. Global Prostate Specific Antigen (PSA) Testing Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global Prostate Specific Antigen (PSA) Testing Market Industry Development
3.1.3. Pre & Post COVID-19 Trends and Scenarios
3.2. Prostate Specific Antigen (PSA) Testing Market Dynamics (Growth Impacting Factors & Rationales)
3.2.1. Drivers
3.2.1.1. Increase the level of awareness
3.2.1.2. Increasing of geriatric patients
3.2.1.3. Information passes to doctor and provide more targeted treatment plan
3.2.1.4. PSA test is the precautionary measure to determine early detection of prostate cancer
3.2.1.5. Driver 5
3.2.2. Restraints
3.2.2.1. Chances of Provision of False Result of PSA Screening Test
3.2.2.2. Restraint 2
3.2.3. Opportunities
3.2.3.1. Technological advancements in testing & treating the prostate cancer
3.2.3.2. Availability of reimbursement policies for the prostate cancer treatments
3.2.3.3. Opportunity 3
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porters Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Average Selling Prices and Pricing Trends Analysis of Prostate Specific Antigen (PSA) Testing Market
3.8. Technological Roadmap
3.9. Key Investment Pockets of Prostate Specific Antigen (PSA) Testing Market
3.9.1. By Test Procedure
3.9.2. By Test Type
3.9.3. By Assays type
3.9.4. By Application
3.9.5. By Regions
4. Global Prostate Specific Antigen (PSA) Testing Market: Estimates & Historic Trend Analysis (2020 to 2021)
4.1. Global Prostate Specific Antigen (PSA) Testing Market, 2020 2021 (US$ Million)
4.2. Global Prostate Specific Antigen (PSA) Testing Market, By Test Procedure, 2020 to 2021 (US$ Million)
4.3. Global Prostate Specific Antigen (PSA) Testing Market, By Test Type, 2020 to 2021 (US$ Million)
4.4. Global Prostate Specific Antigen (PSA) Testing Market, By Assays type, 2020 to 2021 (US$ Million)
4.5. Global Prostate Specific Antigen (PSA) Testing Market, By Application, 2020 to 2021 (US$ Million)
4.6. Global Prostate Specific Antigen (PSA) Testing Market, By Region, 2020 to 2021 (US$ Million)
5. Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Test Procedure
5.1. Global Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, by Test Procedure, 2022 & 2033
5.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Million) Estimates and Forecasts, by Test Procedure, 2023 to 2033
5.2.1. Preliminary Tests
5.2.2. Confirmatory Tests
6. Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Test Type
6.1. Global Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, by Test Type, 2022 & 2033
6.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Million) Estimates and Forecasts, by Test Type, 2023 to 2033
6.2.1. Total Prostate Specific Antigen Test (tPSA)
6.2.2. Complex Prostate Specific Antigen Test (cPSA)
6.2.3. Free Prostate Specific Antigen Test (fPSA)
6.2.4. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test (PSA RT-PCR)
6.2.5. PCA3Test
6.2.6. Trans-rectal Ultrasound
6.2.7. Biopsy
7. Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Assays type
7.1. Global Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, by Assays type, 2022 & 2033
7.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Million) Estimates and Forecasts, by Assays type, 2023 to 2033
7.2.1. Radioimmunoassay (RIA)
7.2.2. Enzyme Immunoassay (EIA)
8. Global Prostate Specific Antigen (PSA) Testing Market Estimates & Forecast Trend Analysis, by Application
8.1. Global Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, by Application, 2022 & 2033
8.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Million) Estimates and Forecasts, by Application, 2023 to 2033
8.2.1. Screening
8.2.2. Post-treatment Monitoring
8.2.3. Others
9. Global Prostate Specific Antigen (PSA) Testing Market Analysis and Forecast, by Region
9.1. Global Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, by Region, 2022 & 2033
9.2. Global Prostate Specific Antigen (PSA) Testing Market Revenue (US$ Million) Estimates and Forecasts, by Region, 2023 to 2033
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Middle East and Africa
9.2.5. Latin America
10. North America Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis
10.1. North America Prostate Specific Antigen (PSA) Testing Market Assessments & Key Findings
10.2. North America Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, 2022 & 2033
10.3. North America Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
10.3.1. By Test Procedure
10.3.2. By Test Type
10.3.3. By Assays type
10.3.4. Application
10.3.5. By Major Country
10.3.5.1. The U.S.
10.3.5.2. Canada
11. Europe Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis
11.1. Europe Prostate Specific Antigen (PSA) Testing Market Assessments & Key Findings
11.2. Europe Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, 2022 & 2033
11.3. Europe Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
11.3.1. By Test Procedure
11.3.2. By Test Type
11.3.3. By Assays type
11.3.4. Application
11.3.5. By Major Country
11.3.5.1. Germany
11.3.5.2. The U.K.
11.3.5.3. France
11.3.5.4. Italy
11.3.5.5. Spain
11.3.5.6. Rest of Europe (includes all other European countries)
12. Asia Pacific Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis
12.1. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Assessments & Key Findings
12.2. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, 2022 & 2033
12.3. Asia Pacific Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
12.3.1. By Test Procedure
12.3.2. By Test Type
12.3.3. By Assays type
12.3.4. Application
12.3.5. By Major Country
12.3.5.1. China
12.3.5.2. Japan
12.3.5.3. India
12.3.5.4. ASEAN
12.3.5.5. South Korea
12.3.5.6. Rest of Asia Pacific (includes all other Asia Pacific countries)
13. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis
13.1. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Assessments & Key Findings
13.2. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, 2022 & 2033
13.3. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
13.3.1. By Test Procedure
13.3.2. By Test Type
13.3.3. By Assays type
13.3.4. Application
13.3.5. By Major Country
13.3.5.1. GCC
13.3.5.2. South Africa
13.3.5.3. Egypt
13.3.5.4. Rest of Middle East & Africa (includes all other Middle East & Africa countries)
14. Latin America Prostate Specific Antigen (PSA) Testing Market: Estimates & Forecast Trend Analysis
14.1. Latin America Market Assessments & Key Findings
14.2. Latin America Prostate Specific Antigen (PSA) Testing Market Share (%) Estimates and Forecasts, 2022 & 2033
14.3. Latin America Prostate Specific Antigen (PSA) Testing Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
14.3.1. By Test Procedure
14.3.2. By Test Type
14.3.3. By Assays type
14.3.4. Application
14.3.5. By Major Country
14.3.5.1. Brazil
14.3.5.2. Mexico
14.3.5.3. Rest of Latin America (includes all other Latin America countries)
15. Competitive Landscape
15.1. Prostate Specific Antigen (PSA) Testing Market Revenue Share Analysis (%), by Major Players (2021)
15.2. Prostate Specific Antigen (PSA) Testing Market Competition Matrix, by Leading Players
15.3. Prostate Specific Antigen (PSA) Testing List of Emerging, Prominent and Leading Players
15.4. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Recent Developments, etc.
16. Company Profiles
16.1. Abbott Laboratories Inc
16.1.1. Company Overview & Insights
16.1.2. Financial Performance
16.1.3. Product / Service Portfolio
16.1.4. Geographical Footprint & Share
16.1.5. Strategic Initiatives & Key Developments
*Similar details would be provided for all the players mentioned below
16.2. Bayer AG.
16.3. Beckman Coulter Inc.
16.4. GE Healthcare
16.5. GlaxoSmithKline plc.
16.6. Novartis Pharma AG.
16.7. UroLogix Inc.
16.8. Bristol - Myers Squibb Company
16.9. AstraZeneca plc.
16.10. MDx Health
16.11. Myriad Genetics Inc
16.12. F. Hoffman-La Roche AG
16.13. Siemens Healthineers AG
16.14. OPKO Health Inc.
16.15. Genomic Health
16.16. DiaSorin
16.17. Roche
16.18. PerkinElmer
16.19. Tosoh
16.20. Ortho Clinical
16.21. Fujirebio
16.22. Mediwatch (LABORIE)
16.23. BodiTech
16.24. Others
17. Assumptions and Research Methodology
17.1. Data Mining
17.2. Secondary Research
17.3. Primary Research
17.4. Subject Matter Expert Advice
17.5. Quality Check
17.6. Final Review
17.7. Data Triangulation
17.8. Bottom-Up Approach
17.9. Top Down Approach
17.10. Research Flow
17.11. Key Insights from Industry Experts
17.12. Data Sources
17.13. Assumptions
17.14. Limitations
18. Conclusions and Recommendations
18.1. Key Research Findings and Conclusion
18.2. Key Insights & Recommendations from Analysts